Newsletter

To OTC Journal Members: 

Our Second Last "Pre Football" Edition

Are you ready for some football? To end? I've really enjoyed this theme- a Sunday morning edition prior to the NFL games. Only the Superbowl remains after today's Championship games.

So, sit back, relax, and read this Sunday's OTC Journal before Baltimore tries to handle Brady and New England, and the NY Football Giants head into San Francisco. Watch for the Niners- a great defense and a good running game can take you a long way this time of year. The Baltimore/New England game is a toss up. Baltimore does not play well on the road. Slight edge to the Pats there.

So, how about this past week? Four ideas so far this year, and here's your update:

• Liberator (OTC BB: LUVU) made a new multi month high this week, trading up to $.23 from the $.15 entry level. Post close news Friday on this one bodes well for Monday trading. A 53% gainer so far.
• As predicted- FrogAds (OTC BB: FROG) jumped from $.24 to $.40 this past week- that's a 66% move this week. I think that one could continue higher next week.
• Dexcom March 10 Calls (DXCM) I recommended at $1.40 closed at $1.40- unchanged. DXCM is rumored to be a good acquisition target.
• Magic Jack March 15 Calls (CALL) I recommended at $1.40 closed at $1.75- a nice 25% gain, but not even close to what I'm looking for.
• Investors who listened to my caution warning on red hot penny stock North Springs (NSRS) might have been a little disappointed. I predicted it would drop 70% in one day, and it only dropped 60%. It did deliver the inevitable bounce, but I suspect the game is over, and the stock will head lower again.

That's 4 gainers and 1 break even this week. If every week was this good. I can only hope. This market is really heating up. The market is not listening as intently to the noise out of Europe, and the economy is perking up nicely. With stocks this cheap, it's a great time to get aggressive.

And, speaking of aggressive, did you catch Friday's post close news on Liberator(LUVU)?- Off a new multi year high this week, it's looking like another strong week might be in the cards. Read on McDuff...........  

Liberator (LUVU) Gets Stern To Expand Revenues

As mentioned above, Liberator (LUVU) made a new multi month high this past week, hitting the $.23 mark. It's not easy to find stocks this low priced with $60 million in total revenues in their history, and $20 million likely this calender year.

In order to boost sales for their traditionally best quarter of the year- CY Q1- Liberator (LUVU) is headed in a new and ideal advertising direction. The self proclaimed "King of All Media" is widely perceived to have invented the "Shock-Jock" genre of radio broadcasting.

Despite his controversial programming, Stern was the unquestioned master of the highly coveted 18-34 male demographic was he broadcast on terrestrial radio. Stern is also credited as a pioneer in the field of syndicating radio content to affiliates around the country.

Since moving to Sirius, Stern's audience has aged a bit- the 35-64 demographic is more likely to listen to Sirius than the younger group.

However, there can be no argument Stern's audience is ideal for LUVU products. The sexual wellness revolution's best spokesperson might be Howard Stern, and his monster demographic will bring a much larger audience to LUVU's products. Advertising will be heavily concentrated around Valentine's Day.

Here's what I'm interested in- will Stern just drive traffic to www.liberator.com? or will Stern mention LUVU's products can be found at Amazon.com and many main stream stores where their products are found?

I'll be listening. Look for LUVU to make another leg up next week on this news. Still very undervalued. Ask yourself how many stocks you own in the $.20 to $.25 range delivering $20 million in annual revenues.

LUVU is likely to continue higher this week. I've been looking for $.30 plus on this one in the first 1 to 2 months, and I believe we'll get it if the stock continues to trade this well and the company delivers news like this.

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them in the form of cash and sometimes restricted securities as payment for publishing information and opinion about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions that the Newsletter or its principals maintain in securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities.  The Newsletter may be deemed to have a conflict of interest between its open market activity and positions in these securities and the timing of and opinions expressed in its publications concerning these companies.  The publications should not be considered to be independent publications concerning the company.

All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation of an offer to buy or sell any securities mentioned. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties. MarketByte LLC has been pledged fees totalling $18,000 for coverage of Frogads by Lake Media Group. MarketByte LLC has been paid a fee of $15,000 for coverge of Liberator, Inc by the company. Larry Isen, the editor and publisher of the OTC Journal, owns 88,000 shaers of LUVU purchased in a private placement at $.25 per share.

READERS  ARE ENCOURAGED TO DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED IN THIS PUBLICATION. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.finra.org. We also recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.

The information found in this profile is protected by the copyright laws of the united states and may not be copied, or reproduced in any way without the expressed, written consent of the editors of otcjournal.com.